PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAbeona Therapeutics
Abeona Therapeutics(ABEO)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Prademagene zamikeracel
epidermolysis bullosa
,
epidermolysis bullosa dystrophica
Bevifimod
factor vii deficiency
,
healthy volunteers/patients
,
alpha 1-antitrypsin deficiency
,
pneumonia
,
inflammation
,
covid-19
,
kidney transplantation
,
hemophilia a
,
hemophilia b
,
graft vs host disease
,
hereditary angioedemas
,
angioedema
,
hereditary angioedema types i and ii
,
immunologic deficiency syndromes
,
primary immunodeficiency diseases
,
infections
,
communicable diseases
,
hemorrhage
,
thromboembolism
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
sinusitis
,
pneumococcal infections
,
otitis media
,
streptococcal infections
,
bacterial pneumonia
,
meningitis
,
bacterial meningitis
,
haemophilus influenzae
,
hereditary complement deficiency diseases
,
neisseriaceae infections
,
lung diseases
,
ataxia
,
ataxia telangiectasia
,
telangiectasis
,
x-linked combined immunodeficiency diseases
,
cerebellar ataxia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use